Cargando…
Pharmacology of COVID-19
Autores principales: | Sureda, Antoni, Habtemariam, Solomon, Nabavi, Seyed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151456/ https://www.ncbi.nlm.nih.gov/pubmed/35662545 http://dx.doi.org/10.1016/j.cbi.2022.110005 |
Ejemplares similares
-
Ginsenoside Rd and ischemic stroke; a short review of literatures()
por: Nabavi, Seyed Fazel, et al.
Publicado: (2015) -
Post-Stroke Depression Modulation and in Vivo Antioxidant Activity of Gallic Acid and Its Synthetic Derivatives in a Murine Model System
por: Nabavi, Seyed Fazel, et al.
Publicado: (2016) -
Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications
por: Nabavi, Seyed Fazel, et al.
Publicado: (2015) -
Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020) -
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
por: Habtemariam, Solomon, et al.
Publicado: (2020)